Finance

Beta
Lists
600267:SHA
Zhejiang Hisun Pharmaceutical Co., Ltd.
CN¥9.66
+1.90%
(+0.18) 1D
Jun 10, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600267...
Open
CN¥9.40
High
CN¥9.68
Low
CN¥9.40
Mkt. cap
11.36B
Avg. vol.
21.25M
Volume
12.22M
P/E ratio
15.98
52-wk high
CN¥13.06
52-wk low
CN¥9.07
EPS
CN¥0.60
Shares outstanding
965.53M
No. of employees
9K
Open
CN¥9.40
High
CN¥9.68
Low
CN¥9.40
Mkt. cap
11.36B
Avg. vol.
21.25M
Volume
12.22M
P/E ratio
15.98
52-wk high
CN¥13.06
52-wk low
CN¥9.07
EPS
CN¥0.60
Shares outstanding
965.53M
No. of employees
9K
News stories
From sources across the web
About Zhejiang Hisun Pharmaceutical Co., Ltd.
CEO-
Employees8.75K
Founded1956
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.62B
2.67B
2.63B
2.39B
Cost of goods sold
1.47B
1.37B
1.58B
1.17B
Cost of revenue
1.47B
1.37B
1.58B
1.17B
Research and development expenses
109.94M
169.79M
106.39M
134.44M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
733.72M
767.80M
723.79M
706.45M
Operating expense
916.41M
924.27M
897.41M
845.10M
Total operating expenses
2.39B
2.29B
2.48B
2.02B
Operating income
232.55M
382.05M
149.99M
370.87M
Other non operating income
647.38K
-22.42M
21.53M
-3.69M
EBT including unusual items
154.91M
215.43M
195.64M
482.46M
EBT excluding unusual items
212.24M
337.55M
149.16M
529.80M
Income tax expense
46.80M
52.29M
116.21M
123.91M
Effective tax rate
30.21%
24.27%
59.40%
25.68%
Other operating expenses
27.57M
-14.72M
61.27M
12.09M
Net income
104.84M
161.86M
79.78M
355.69M
Net profit margin
4.00%
6.06%
3.04%
14.88%
Earnings per share
-
-
-
-
Interest and investment income
3.99M
2.80M
3.79M
179.34M
Interest expense
-26.07M
-23.75M
-21.61M
-16.72M
Net interest expenses
-22.08M
-20.95M
-17.82M
162.62M
Depreciation and amortization charges
-
-
-
-
EBITDA
473.41M
648.89M
388.47M
609.35M
Gain or loss from assets sale
-305.01K
305.01K
-5.23M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more